A systematic review and meta-analysis of efficacy and safety following holmium laser enucleation of prostate and transurethral resection of prostate for benign …

J Zhong, Z Feng, Y Peng, H Liang - Urology, 2019 - Elsevier
Transurethral resection of prostate (TURP) still remains the “gold standard” surgical
treatment for benign prostatic hyperplasia (BPH). In recent years, holmium laser enucleation …

Efficacy and safety of hexanic lipidosterolic extract of Serenoa repens (Permixon) in the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia …

G Novara, G Giannarini, A Alcaraz, JM Cozar-Olmo… - European urology …, 2016 - Elsevier
Abstract Context A recent Cochrane Collaboration meta-analysis of randomized controlled
trials (RCTs) evaluating the efficacy of different extracts of Serenoa repens in relieving lower …

Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non …

D Abt, L Hechelhammer, G Müllhaupt, S Markart… - Bmj, 2018 - bmj.com
Objective To compare prostatic artery embolisation (PAE) with transurethral resection of the
prostate (TURP) in the treatment of lower urinary tract symptoms secondary to benign …

Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3 …

M Sapoval, N Thiounn, A Descazeaud… - The Lancet Regional …, 2023 - thelancet.com
Background Prostatic artery embolisation (PAE) is a minimally invasive treatment of
symptomatic benign prostatic hyperplasia (BPH). Our aim was to compare patient's …

Outcome prediction of prostatic artery embolization: post hoc analysis of a randomized, open‐label, non‐inferiority trial

D Abt, G Müllhaupt, L Mordasini, S Güsewell… - BJU …, 2019 - Wiley Online Library
Objectives To identify predictors for different treatment outcomes after prostatic artery
embolization (PAE) in the treatment of lower urinary tract symptoms secondary to benign …

Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment—the QUALIPROST study

A Alcaraz, J Carballido-Rodríguez… - … urology and nephrology, 2016 - Springer
Purpose To evaluate change in quality of life (QoL) and symptoms in patients with lower
urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) in conditions of current …

Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination …

L Cindolo, L Pirozzi, P Sountoulides, C Fanizza… - BMC urology, 2015 - Springer
Background Recent studies showed that the non-adherence to the pharmacological therapy
of patients affected by BPH-associated LUTS increased the risk of clinical progression of …

Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study

S Kaplan, RP Kaufman Jr, T Mueller… - Prostate Cancer and …, 2024 - nature.com
Background Up to 50% of men over 50 and 80% over 80 are affected by BPH. Shared
decision-making regarding BPH treatment options can benefit from an improved …

Treatment of benign prostate hyperplasia using the Rezum® water vapor therapy system: results at one year

C Alegorides, M Fourmarier, C Eghazarian, S Lebdai… - Progrès en Urologie, 2020 - Elsevier
Purpose To report the results of convective radiofrequency (RF) water vapor thermal therapy
in men with lower urinary tract symptoms (LUTS) associated with benign prostatic …

What is the required certainty of evidence for the implementation of novel techniques for the treatment of benign prostatic obstruction?

MJ Speakman, JN Cornu, M Gacci, C Gratzke… - European urology …, 2019 - Elsevier
Context A large number of minimally invasive techniques have been developed for the
surgical management of male lower urinary tract symptoms (LUTS) presumed to be …